AMRX Exercise Disclosure
Buchi J Kevin · SEC Form 4 · Filed Sep 14, 2026
Exercise
Calculated transaction value
$0
Buchi J Kevin Director
AMRX
Transaction date
Sep 11, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 3 days later
AMRX daily price context
Close on/before transaction
$17.01
Sep 11, 2026
Close before public filing
$17.01
Sep 11, 2026
Return since public filing
-0.21%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Class A Common Stock
- Quantity / price
- 20,445 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-061836
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$295.43K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX | Exercise | Sep 11, 2026 | $295.43K |
| Amneal Pharmaceuticals, Inc. AMRX Current | Exercise | Sep 11, 2026 | $0 |